chauezhelolocu1622.blogspot.com
The money was granted in collaboration withthe U.S. Army Medicao Research and Materiel Command and the throughthe Ft. Detrick Technologhy Transfer Initiative. The purpose of the technology transfer program is to raise awareness of new and developingb technologies and funding them to transition as viable projectsfor follow-on funding in the market Each company that received funding was awarded approximately $50,0009 between March 2008 and May 2009, making up the initiative’s second round of financial awards since its $750,00p program extension. The funds for the program’es second phase were secured by Sen. Barbara Mikulski, and Rep. Roscoe G. Bartlett, R-Md. “The [Ft.
Detrickl Technology Transfer Initiative] program is enabling area businesses to harnessw the technologies being developed at Fort Detrick and applt them to thecommercial sector,” said Mikulski. “This will lead to new productas that have the power to creatd jobs andsave lives.” Mikulski announced the first phase of the tech transfer program in Marcgh 2005 when 11 companies received funding. in Rockville: The companyt is developing a health care technologuy calledmiTag system, which is a scalable wireless sensor solutiomn for improving patient flow. in The company is developing a technologgy called the GeNova Screemnto identify, isolate, and producwe antibody-like molecules.
in Rockville: The compant is developing an on-demand biotecy products including a combinationj vaccine against plagueand anthrax. BioAssay Works LLC in The company is developinfa lateral-flow visual diagnostic test to detect and differentiate singld sample multiple pathogenic poxviruses, including vaccinia, and monkeypox. in Catonsville: The companyy is safety-testing a medical product called ClotFoam, which is a intracavitary hemostatic agent.
CynerGene IDMP in The companyis developing, validatinfg and implementing a supplemental diagnosis of Malaria, HIV, and Dengue using its Infectious Disease Multiplex Panelp approach, which could allow for creation of LLC in Baltimore: The company is developing required components and system framework to enabls conversational interfaces for telemedicinse tools. Such tools would allow professionaol medics touse voice, and other human-- computer interactions to access and documenft information in electronic medical records. in The company is developing technologyh to preserve mammalian cells in dried format that can easilybe re-hydrated for a varietu of uses.
LLC in Frederick: The companyh is evaluating the effect of Imagilin patentefd probiotics as a food supplement to enhancw the immune responsiveness of guinea pigs upon immunization or challengew withvirulent pathogens. The evaluationh will suggest the ability of Imagilin patented probiotic to enhance the immunizatiohn ofa vaccine. in Baltimore: The company is developing micropatternef substrates for viralinfectivity assays. Juxtopia in The company is customizing its Wearable Assistancwe and SituationalAwareness (WASA) goggles and service to allow U.S.
Army combat medicws to access and document informatiobn to electrical medical recordsvia hands-free voice-requests and in Baltimore: The company is developing cell therapies to treat brain and spinal cord injuries.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment